CompuGroup Medical Acquires Majority Stake in Patient Portal Provider m.Doc

CompuGroup Medical SECompuGroup Medical SE & Co. KGaA has acquired 51% of m.Doc GmbH. m.Doc develops patient portals and digital applications for hospitals, rehabilitation and care facilities. Founded in 2016, the company has offices in Cologne and Lisbon with around 110 employees. CompuGroup Medical will further develop m.Doc's patient portal and integrate it into its systems. CompuGroup Medical will also extend the CLICKDOC solution for appointment booking and video consultations and leverage synergies for messenger solutions. The transaction is an important milestone towards enabling the full digital patient journey in both inpatient and outpatient settings and optimizes referrals from general practitioners to hospitals.

m.Doc focuses on digitizing everyday hospital life, integrating patients into administrative and medical processes before, during and after inpatient treatment, and providing far-reaching relief and support for medical staff. The technical basis for the m.Doc applications is the Smart Health Platform, which connects m.Doc's modular patient portal with services such as video consultations, appointment booking, medication plans, treatment documents and much more. The interoperability of the m.Doc platform with all common hospital information systems will be further promoted for the benefit of customers and partners. m.Doc's vision that everyone can reach their doctor anytime and anywhere via mobile devices fits perfectly with CompuGroup Medical's purpose: "Nobody should suffer or die because at some point medical information was missing."

"The acquisition of m.Doc is an excellent addition to our product portfolio. With m.Doc, we acquire a product suite with an attractive customer base of more than 300 hospitals, making us one of the leading providers in the digital integration of patients into the treatment process in the inpatient sector," emphasizes Hannes Reichl, Managing Director Inpatient and Social Care at CompuGroup Medical SE & Co. KGaA. "Especially in the hospital sector, there is a high demand for new solutions of digital patient communication. This development is gaining additional momentum due to the German Hospital Future Act."

"With CompuGroup Medical, we are entering the next phase of our growth. The financial strength of the group, the large customer base and especially the experience in implementing complex projects are an enormous added value for us as a team and for our customers. In addition, we will work on deep integration with CompuGroup Medical's solutions to offer a fully integrated end-to-end patient journey," says Admir Kulin, Managing Director of m.Doc GmbH, looking positively to the future.

About CompuGroup Medical SE & Co. KGaA

CompuGroup Medical is one of the leading e-health companies in the world. With a revenue base of EUR 1.130 billion in 2022, its software products are designed to support all medical and organizational activities in doctors’ offices, pharmacies, laboratories, hospitals and social welfare institutions. Its information services for all parties involved in the healthcare system and its webbased personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1.6 million users, including doctors, dentists, pharmacists and other healthcare professionals in inpatient and outpatient facilities. With locations in 20 countries and products in 60 countries worldwide, CompuGroup Medical is the e-health company with one of the highest coverages among healthcare professionals. More than 9,200 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...